Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy

Author： Shin Sang joon   Lee Hye Won   Kim Se Hyun   Ahn Joong Bae   Choi Hye Jin   Cho Byoung Chul   Jeung Hei-Cheul   Rha Sun Young   Chung Hyun Cheol   Pyo Ju Yeon   Roh Jae Kyung  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.46, Iss.4, 2007-01, pp. : 547-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Chemotherapy in Non-Small Cell Lung Cancer

By Rosell Rafael  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 211-212

Adis International

Access to resources Recommend Favorite

Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

By Solomon Benjamin   Bunn Paul A.  

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 217-225

Informa Healthcare

Access to resources Recommend Favorite

Short-term outcomes of cetuximab combined with standard chemotherapy as non-first line setting for patients with non-small cell lung cancer: a report of 6 cases

By Wang Fang   Xia Liangping   Guo Guifang   Qiu Huijuan   Zhou Feifei   Zhang Bei   Zhang Li  

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 9, 2010-09 ,pp. : 502-506

Springer Publishing Company

Access to resources Recommend Favorite

Patient versus clinician preferences for chemotherapy in non-small-cell lung cancer

By Long Anne   Ferraro Danielle   Stockler Martin   Blinman Prunella  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 527-536

Future Medicine

Access to resources Recommend Favorite

Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer

By            

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1135-1140

Spandidos Publications

Access to resources Recommend Favorite